Skip to main content
19 May 2024
Last updated:
Friday 10 May 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
The stakes for biopharma from German drug policy
Read more
Johnson & Johnson brings partnering to the frontline
Read more
How BioCity Nottingham is rebuilding pharma
Read more
Small molecules or biologics: that's the question
Read more
Are botanical drugs a new model for pharma?
Read more
A start-up genomics company explains why open-source software is important
Read more
Time to engage with stem-cell therapy
Read more
Interview: 4-Antibody AG - How do you structure a biotech for divestment?
Read more
A Big Pharma deal that shares risk and reward
Read more
Focus on ophthalmology: new treatment modality
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
14
Page
15
Page
16
Page
17
Page
18
Current page
19
Page
20
Page
21
Page
22
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form